Humoral mediation for cachexia in tumour-bearing rats.
Early and severe loss of body weight associated with pronounced tissue changes developed in rats transplanted with a fast-growing ascites hepatoma (Yoshida AH-130). The protein content showed an early and marked fall in the skeletal muscle, while in the liver it transiently increased 4 days after implantation then declined to values lower than in control animals. Protein loss in gastrocnemius muscle and liver resulted mainly from enhancement of protein catabolism (Tessitore L. et al., Biochem. J., 241: 153-158, 1987). In contrast to the tumour-bearing rats, in the pair-fed animals the initial body weight was maintained, while the protein mass decreased sharply in the liver and moderately in the gastrocnemius muscle. In host animals total plasma protein decreased during the period of tumour growth, while both triglycerides and total cholesterol markedly increased. Glucose remained unchanged even when overt cachexia had developed. The total free amino acid concentration in the plasma of tumour-bearing rats decreased slightly by day 4 and returned to values close to those of controls in the late stages of tumour growth. By contrast, in the pair-fed controls the plasma levels of triglycerides and particularly of total free amino acids and glucose decreased over the whole experimental period, whereas total protein and cholesterol were unchanged. Marked perturbations in the hormonal homeostasis developed early after tumour transplantation. The plasma levels of glucagon, corticosterone and catecholamines rose sharply, while those of insulin and thyroid hormones decreased. Furthermore, high plasma concentrations of prostaglandin E2 (PGE2) and tumour necrosis factor (TNF) were observed over the whole experimental period. IL-1-like activity, TNF and PGE2 were released in vitro from AH-130 cells. These data suggest that the systemic effects of AH-130 tumour on the host rat reflected the interplay of a complex network of factors, including classical hormones and cytokines, all of which likely concur in enhancing tissue protein catabolism.
Tessitore
L
L
Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.
Costelli
P
P
Baccino
F M
FM
D000818:Animals; D001835:Body Weight / Q000502:physiology; D002100:Cachexia / Q000097:blood / Q000209:etiology / Q000378:metabolism*; D015232:Dinoprostone / Q000097:blood; D006706:Homeostasis / Q000502:physiology; D006728:Hormones / Q000097:blood / Q000378:metabolism; D007375:Interleukin-1 / Q000097:blood; D008099:Liver / Q000033:anatomy & histology / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000097:blood / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D009132:Muscles / Q000033:anatomy & histology / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D009368:Neoplasm Transplantation; D009929:Organ Size / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D006728:Hormones; D007375:Interleukin-1; D009363:Neoplasm Proteins; D014409:Tumor Necrosis Factor-alpha; D015232:Dinoprostone